Cargando…

Erratum: SH2 Domain–Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159419/ https://www.ncbi.nlm.nih.gov/pubmed/32293203 http://dx.doi.org/10.1164/rccm.v201erratum3

Ejemplares similares

Erratum to collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
Publicado: (2022)

SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma
por: Tai, Wei-Tien, et al.
Publicado: (2016)

Erratum: Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
Publicado: (2021)

Erratum to: Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer
por: Qiu, Jianguang, et al.
Publicado: (2017)

Erratum to spliceosome-associated protein 130: a novel biomarker for idiopathic pulmonary fibrosis
Publicado: (2021)

SH2 domain‐containing protein tyrosine phosphatase‐2 is enriched in eyelid specimens of rosacea
por: Chebolu, Apoorv, et al.
Publicado: (2022)

Erratum to: Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer’s Disease
por: Wei, Hui, et al.
Publicado: (2020)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Erratum to “Factors Influencing Oxidative Imbalance in Pulmonary Fibrosis: An Immunohistochemical Study”
por: Inghilleri, S., et al.
Publicado: (2011)

Erratum: Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
Publicado: (2021)

Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group
Publicado: (2022)

Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes
por: O’Dwyer, David N., et al.
Publicado: (2017)

Evidence for SH2 Domain-Containing 5′-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction
por: Agollah, Germaine D., et al.
Publicado: (2014)

Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition: Erratum
por: Wang, Qi, et al.
Publicado: (2022)

Erratum to “A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-PGJ(2)”
por: Wallace, Dorothy I., et al.
Publicado: (2017)

Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis
por: Skurikhin, Evgenii, et al.
Publicado: (2020)

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Crucial Role of miR-433 in Regulating Cardiac Fibrosis: Erratum
por: Tao, Lichan, et al.
Publicado: (2021)

Erratum: XBP1S Regulates MUC5B in a Promoter Variant–Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia
Publicado: (2019)

Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016)

Erratum to: Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer
por: Stella, Giulia M., et al.
Publicado: (2017)

Erratum to “Expression Analysis of Fibronectin Type III Domain-Containing (FNDC) Genes in Inflammatory Bowel Disease and Colorectal Cancer”
por: Wuensch, Tilo, et al.
Publicado: (2020)

Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
por: Costabel, Ulrich, et al.
Publicado: (2014)

Erratum: Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry
Publicado: (2023)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
por: Lyu, Xing, et al.
Publicado: (2019)

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
por: Maher, Toby M., et al.
Publicado: (2019)

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021)

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
por: Li, Ji-Min, et al.
Publicado: (2023)

Erratum to: In vivo role of different domains and of phosphorylation in the transcription factor Nkx2-1
por: Silberschmidt, Daniel, et al.
Publicado: (2016)

ERRATUM 2
Publicado: (2010)

Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: A Series of 49 Patients and Review of the Literature: Erratum
Publicado: (2015)

The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin
por: Dyson, Jennifer M., et al.
Publicado: (2001)

Erratum: Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak
Publicado: (2020)

Erratum to: The altered gut microbiota in adults with cystic fibrosis
por: Burke, D.G., et al.
Publicado: (2017)

Erratum: PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Zhang, Huizhi, et al.
Publicado: (2017)

Trehalose inhibits H(2)O(2)-induced autophagic death in dopaminergic SH-SY5Y cells via mitigation of ROS-dependent endoplasmic reticulum stress and AMPK activation: Erratum
por: Gao, Zhijie, et al.
Publicado: (2023)

Erratum to: Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria
por: Nisar, R., et al.
Publicado: (2015)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?: Erratum
Publicado: (2015)

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
por: George, Peter M, et al.
Publicado: (2020)

Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
por: Murray, Lynne A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c0ulcflpl1e24gaor5lag7514k